Heartburn medication Zantac recalled in Canada and US over contamination fears

Marco Green
October 21, 2019

The French company Friday joined other drugmakers that have recently recalled their versions of the popular heartburn and ulcer drug.

There's fears the drug could be contaminated with a potentially cancer-causing chemical.

Sanofi said that the recall applied only to the United States and Canada, and that its products sold outside the two countries were sourced from different suppliers. This has now been updated to include additional products from Sanofi Consumer Health Inc., Sivem Pharmaceuticals ULC and Teva Canada Limited.

While the statement notes that Canadians are continually exposed to low levels of the NDMA impurity on a daily basis in meat, vegetables and drinking water, it explains that it is not risky when ingested at very low levels.

For now, companies have stopped the distribution of all ranitidine drugs across Canada until more tests are done to confirm that NDMA levels in these products are safe for consumption.

The FDA has advised people who use over-the-counter versions of Zantac to consider using another heartburn medication.

A list of the products and batch numbers that have been recalled can be found on the FDA's official Web site, www.fda.gov.tw, under the "stomach medicine abnormal events information" section on the Chinese-language main page. Those concerned should speak to a doctor or pharmacist.

The remaining 23 products must be recalled before November 18, Hung said, adding that some of them contained NDMA exceeding the allowable limit, some did not turn in the report before the deadline and some were voluntarily recalled by the manufacturer.

Global health regulators revealed earlier this month that they were reviewing the safety of ranitidine.

There are stories everywhere.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER